Sanofi goes deeper into the lead
The French group takes a shot at Perspective with its second bet on Orano Med.
Bristol makes its radiopharma move
The group’s $4.1bn swoop for RayzeBio follows big deals from Novartis and Lilly.
The French group takes a shot at Perspective with its second bet on Orano Med.
The group’s $4.1bn swoop for RayzeBio follows big deals from Novartis and Lilly.
